Hiroaki Kimura

2.0k total citations
75 papers, 1.4k citations indexed

About

Hiroaki Kimura is a scholar working on Biotechnology, Genetics and Biomedical Engineering. According to data from OpenAlex, Hiroaki Kimura has authored 75 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Biotechnology, 28 papers in Genetics and 23 papers in Biomedical Engineering. Recurrent topics in Hiroaki Kimura's work include Cancer Research and Treatments (43 papers), Virus-based gene therapy research (27 papers) and Nanoplatforms for cancer theranostics (21 papers). Hiroaki Kimura is often cited by papers focused on Cancer Research and Treatments (43 papers), Virus-based gene therapy research (27 papers) and Nanoplatforms for cancer theranostics (21 papers). Hiroaki Kimura collaborates with scholars based in Japan, United States and Thailand. Hiroaki Kimura's co-authors include Hiroyuki Tsuchiya, Norio Yamamoto, Katsuhiro Hayashi, Shinji Miwa, Robert M. Hoffman, Kentaro Igarashi, Shunsuke Fujibayashi, Bungo Otsuki, Shuichi Matsuda and Takashi Higuchi and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Spine and Cancer Letters.

In The Last Decade

Hiroaki Kimura

70 papers receiving 1.4k citations

Peers

Hiroaki Kimura
Comparison fields: 5 of 79
  • Biotechnology 491
  • Surgery 426
  • Pulmonary and Respiratory Medicine 345
  • Biomedical Engineering 341
  • Genetics 317
Replace Kentaro Miyake with:
Kentaro Miyake Japan
Shaojun Hu China
Yasuaki Aoki Japan
Kunihiro Masuda Japan
Shuichi Kawashiri Japan
Xin Tang China
Ana Gudelj Gračanin Netherlands
Narikazu Uzawa Japan
Tomoya Sakabe Japan
Weike Si China
Kentaro Miyake Japan View profile →
Citations per field, relative to Hiroaki Kimura
Hiroaki Kimura · 1×
Citations per year, relative to Hiroaki Kimura
Hiroaki Kimura · 1×

Countries citing papers authored by Hiroaki Kimura

Since Specialization
Citations

This map shows the geographic impact of Hiroaki Kimura's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroaki Kimura with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroaki Kimura more than expected).

Fields of papers citing papers by Hiroaki Kimura

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroaki Kimura. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroaki Kimura. The network helps show where Hiroaki Kimura may publish in the future.

Co-authorship network of co-authors of Hiroaki Kimura

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroaki Kimura. A scholar is included among the top collaborators of Hiroaki Kimura based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroaki Kimura. Hiroaki Kimura is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1
Recombinant Methioninase Increases Eribulin Efficacy 16-fold in Highly Eribulin-resistant HT1080 Fibrosarcoma Cells, Demonstrating Potential to Overcome the Clinical Challenge of Drug-resistant Soft-tissue Sarcoma
2024 ·Anticancer Research ·Sei Morinaga, Qinghong Han, (unknown), Byung Mo Kang, (unknown), Michael Bouvet, Norio Yamamoto, Katsuhiro Hayashi, Hiroaki Kimura, (unknown), Kentaro Igarashi, (unknown), (unknown), (unknown), Robert M. Hoffman
1
2
Review: Precise sarcoma patient-derived orthotopic xenograft (PDOX) mouse models enable identification of novel effective combination therapies with the cyclin-dependent kinase inhibitor palbociclib: A strategy for clinical application
2022 ·Frontiers in Oncology ·Takashi Higuchi, Kentaro Igarashi, Norio Yamamoto, Katsuhiro Hayashi, Hiroaki Kimura, Shinji Miwa, Michael Bouvet, Hiroyuki Tsuchiya, Robert M. Hoffman
11
3
Multifocal Epithelioid Hemangioendothelioma Complicated with Disseminated Intravascular Coagulation
2021 ·Case Reports in Oncology ·Hiroaki Kimura, Norio Yamamoto, Katsuhiro Hayashi, Takashi Higuchi, Hiroyuki Tsuchiya
2
4
Recombinant Methioninase Combined With Tumor-targeting Salmonella typhimurium A1-R Induced Regression in a PDOX Mouse Model of Doxorubicin-resistant Dedifferentiated Liposarcoma
2020 ·Anticancer Research ·Kentaro Igarashi, Kei Kawaguchi, Ming Zhao, Qinghong Han, Yuying Tan, Tasuku Kiyuna, Kentaro Miyake, Takashi Higuchi, Scott D. Nelson, Sarah Dry, Yunfeng Li, Norio Yamamoto, Katsuhiro Hayashi, Hiroaki Kimura, Shinji Miwa, Shree Ram Singh, Hiroyuki Tsuchiya, Robert M. Hoffman
5
5
A Novel Anionic-phosphate-platinum Complex Effectively Targets a Cisplatinum-resistant Osteosarcoma in a Patient-derived Orthotopic Xenograft Mouse Model
2020 ·Cancer Genomics & Proteomics ·Kentaro Igarashi, Kei Kawaguchi, Norio Yamamoto, Katsuhiro Hayashi, Hiroaki Kimura, Shinji Miwa, Takashi Higuchi, Yuta Taniguchi, Hirotaka Yonezawa, Yoshihiro Araki, Sei Morinaga, (unknown), Scott D. Nelson, Sarah Dry, Yunfeng Li, Akira Odani, Shree Ram Singh, Hiroyuki Tsuchiya, Robert M. Hoffman
9
6
Eribulin Regresses a Doxorubicin-resistant Dedifferentiated Liposarcoma in a Patient-derived Orthotopic Xenograft Mouse Model
2020 ·Cancer Genomics & Proteomics ·Kentaro Igarashi, Kei Kawaguchi, Tasuku Kiyuna, Kentaro Miyake, Takashi Higuchi, Norio Yamamoto, Katsuhiro Hayashi, Hiroaki Kimura, Shinji Miwa, Shree Ram Singh, Hiroyuki Tsuchiya, Robert M. Hoffman
3
7
Trabectedin and irinotecan combination regresses a cisplatinum-resistant osteosarcoma in a patient-derived orthotopic xenograft nude-mouse model
2019 ·Biochemical and Biophysical Research Communications ·Takashi Higuchi, Kentaro Miyake, Hiromichi Oshiro, Norihiko Sugisawa, Norio Yamamoto, Katsuhiro Hayashi, Hiroaki Kimura, Shinji Miwa, Kentaro Igarashi, Sant P. Chawla, Michael Bouvet, Shree Ram Singh, Hiroyuki Tsuchiya, Robert M. Hoffman
35
8
Combination of oral recombinant methioninase and decitabine arrests a chemotherapy-resistant undifferentiated soft-tissue sarcoma patient-derived orthotopic xenograft mouse model
2019 ·Biochemical and Biophysical Research Communications ·Takashi Higuchi, Qinghong Han, Kentaro Miyake, Hiromichi Oshiro, Norihiko Sugisawa, Yuying Tan, Norio Yamamoto, Katsuhiro Hayashi, Hiroaki Kimura, Shinji Miwa, Kentaro Igarashi, Michael Bouvet, Shree Ram Singh, Hiroyuki Tsuchiya, Robert M. Hoffman
26
9
Patient-derived orthotopic xenograft models of sarcoma
2019 ·Cancer Letters ·Kentaro Igarashi, Kei Kawaguchi, Takashi Murakami, Kentaro Miyake, Tasuku Kiyuna, Masuyo Miyake, Yukihiko Hiroshima, Takashi Higuchi, Hiromichi Oshiro, Scott D. Nelson, Sarah Dry, Yunfeng Li, Norio Yamamoto, Katsuhiro Hayashi, Hiroaki Kimura, Shinji Miwa, Shree Ram Singh, Hiroyuki Tsuchiya, Robert M. Hoffman
19
10
The combination of oral-recombinant methioninase and azacitidine arrests a chemotherapy-resistant osteosarcoma patient-derived orthotopic xenograft mouse model
2019 ·Cancer Chemotherapy and Pharmacology ·Takashi Higuchi, Norihiko Sugisawa, Jun Yamamoto, Hiromichi Oshiro, Qinghong Han, Norio Yamamoto, Katsuhiro Hayashi, Hiroaki Kimura, Shinji Miwa, Kentaro Igarashi, Yuying Tan, Suresh V. Kuchipudi, Michael Bouvet, Shree Ram Singh, Hiroyuki Tsuchiya, Robert M. Hoffman
37
11
The combination of olaratumab with gemcitabine and docetaxel arrests a chemotherapy-resistant undifferentiated soft-tissue sarcoma in a patient-derived orthotopic xenograft mouse model
2019 ·Cancer Chemotherapy and Pharmacology ·Takashi Higuchi, Kentaro Miyake, Norihiko Sugisawa, Hiromichi Oshiro, Zhiying Zhang, Sahar Razmjooei, Norio Yamamoto, Katsuhiro Hayashi, Hiroaki Kimura, Shinji Miwa, Kentaro Igarashi, Michael Bouvet, Shree Ram Singh, Hiroyuki Tsuchiya, Robert M. Hoffman
7
12
The combination of gemcitabine and nab-paclitaxel as a novel effective treatment strategy for undifferentiated soft-tissue sarcoma in a patient-derived orthotopic xenograft (PDOX) nude-mouse model
2019 ·Biomedicine & Pharmacotherapy ·Takashi Higuchi, Kei Kawaguchi, Kentaro Miyake, Hiromichi Oshiro, Zhiying Zhang, Sahar Razmjooei, Sintawat Wangsiricharoen, Kentaro Igarashi, Norio Yamamoto, Katsuhiro Hayashi, Hiroaki Kimura, Shinji Miwa, Scott D. Nelson, Sarah Dry, Yunfeng Li, Sant P. Chawla, Frederick C. Eilber, Shree Ram Singh, Hiroyuki Tsuchiya, Robert M. Hoffman
11
13
Sorafenib and Palbociclib Combination Regresses a Cisplatinum-resistant Osteosarcoma in a PDOX Mouse Model
2019 ·Anticancer Research ·Takashi Higuchi, Norihiko Sugisawa, Kentaro Miyake, Hiromichi Oshiro, Norio Yamamoto, Katsuhiro Hayashi, Hiroaki Kimura, Shinji Miwa, Kentaro Igarashi, Sant P. Chawla, Michael Bouvet, Shree Ram Singh, Hiroyuki Tsuchiya, Robert M. Hoffman
25
14
Tumor-targeting Salmonella typhimurium A1-R is a highly effective general therapeutic for undifferentiated soft tissue sarcoma patient-derived orthotopic xenograft nude-mouse models
2018 ·Biochemical and Biophysical Research Communications ·Kentaro Igarashi, Kei Kawaguchi, Tasuku Kiyuna, Kentaro Miyake, Masuyo Miyake, Arun S. Singh, Mark A. Eckardt, Scott D. Nelson, Tara A. Russell, Sarah Dry, Yunfeng Li, Norio Yamamoto, Katsuhiro Hayashi, Hiroaki Kimura, Shinji Miwa, Hiroyuki Tsuchiya, Shree Ram Singh, Fritz C. Eilber, Robert M. Hoffman
26
15
Knee joint preservation surgery in osteosarcoma using tumour-bearing bone treated with liquid nitrogen
2017 ·International Orthopaedics ·Takashi Higuchi, Norio Yamamoto, Hideji Nishida, Katsuhiro Hayashi, Akihiko Takeuchi, Hiroaki Kimura, Shinji Miwa, Hiroyuki Inatani, (unknown), Takashi Kato, Yu Aoki, Kensaku Abe, Yuta Taniguchi, Hiroyuki Tsuchiya
18
16
Fluorescence-guided surgery of prostate cancer bone metastasis
2014 ·Journal of Surgical Research ·Shinji Miwa, Yasunori Matsumoto, Yukihiko Hiroshima, Shuya Yano, Fuminari Uehara, Mako Yamamoto, Yong Zhang, Hiroaki Kimura, Katsuhiro Hayashi, Norio Yamamoto, Michael Bouvet, Naotoshi Sugimoto, Hiroyuki Tsuchiya, Robert M. Hoffman
10
17
Efficacy of triplet regimen antiemetic therapy for chemotherapy‐induced nausea and vomiting (CINV) in bone and soft tissue sarcoma patients receiving highly emetogenic chemotherapy, and an efficacy comparison of single‐shot palonosetron and consecutive‐day granisetron for CINV in a randomized, single‐blinded crossover study
2014 ·Cancer Medicine ·Hiroaki Kimura, Norio Yamamoto, Toshiharu Shirai, Hideji Nishida, Katsuhiro Hayashi, Yoshikazu Tanzawa, Akihiko Takeuchi, Kentaro Igarashi, Hiroyuki Inatani, (unknown), Takashi Kato, Yu Aoki, Takashi Higuchi, Hiroyuki Tsuchiya
15
18
Effect of Indirect Neural Decompression Through Oblique Lateral Interbody Fusion for Degenerative Lumbar Disease
2014 ·Spine ·Shunsuke Fujibayashi, Richard A. Hynes, Bungo Otsuki, Hiroaki Kimura, Mitsuru Takemoto, Shuichi Matsuda
218
19
Usefulness of the ED Coil Inifini for the treatment of direct carotid-cavernous fistula: techinical note
2012 ·Journal of Neuroendovascular Therapy ·Atsuhiro Kojima, Satoshi Onozuka, Mami Ishikawa, (unknown), Hiroaki Kimura
2
20
Activity of bone morphogenetic protein-7 after treatment at various temperatures: Freezing vs. pasteurization vs. allograft
2011 ·Cryobiology ·(unknown), Naotoshi Sugimoto, Norio Yamamoto, Toshiharu Shirai, Katsuhiro Hayashi, Hideji Nishida, Yoshikazu Tanzawa, Hiroaki Kimura, Shinji Miwa, Akihiko Takeuchi, Hiroyuki Tsuchiya
57

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kentaro Miyake Breakdown of academic impact, for papers by Shaojun Hu Breakdown of academic impact, for papers by Yasuaki Aoki Breakdown of academic impact, for papers by Kunihiro Masuda Breakdown of academic impact, for papers by Shuichi Kawashiri Breakdown of academic impact, for papers by Xin Tang Breakdown of academic impact, for papers by Ana Gudelj Gračanin Breakdown of academic impact, for papers by Narikazu Uzawa Breakdown of academic impact, for papers by Tomoya Sakabe Breakdown of academic impact, for papers by Weike Si
Rankless by CCL
2026